| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |